144 related articles for article (PubMed ID: 21523388)
1. Mathematical modeling to distinguish cell cycle arrest and cell killing in chemotherapeutic concentration response curves.
Hamed SS; Roth CM
J Pharmacokinet Pharmacodyn; 2011 Jun; 38(3):385-403. PubMed ID: 21523388
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid increases the in vitro effects of nitrosureas on human glioma cell lines.
Ciusani E; Balzarotti M; Calatozzolo C; de Grazia U; Boiardi A; Salmaggi A; Croci D
Oncol Res; 2007; 16(10):453-63. PubMed ID: 18196869
[TBL] [Abstract][Full Text] [Related]
3. Tunicamycin induces resistance to camptothecin and etoposide in human hepatocellular carcinoma cells: role of cell-cycle arrest and GRP78.
Hsu JL; Chiang PC; Guh JH
Naunyn Schmiedebergs Arch Pharmacol; 2009 Nov; 380(5):373-82. PubMed ID: 19777212
[TBL] [Abstract][Full Text] [Related]
4. [The effect of Bcl-2 gene silencing on the sensitivity of cell line A549 to chemotherapeutic drugs].
Wang JQ; Du ZW; Gao XF; Wu M; Zhang YC; Pan Y; Wang Q; Zhang GZ
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):191-7. PubMed ID: 23856142
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of 90-kD heat shock protein potentiates the cytotoxicity of chemotherapeutic agents in human glioma cells.
Ohba S; Hirose Y; Yoshida K; Yazaki T; Kawase T
J Neurosurg; 2010 Jan; 112(1):33-42. PubMed ID: 19408974
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivity.
Jensen PB; Roed H; Sehested M; Demant EJ; Vindeløv L; Christensen IJ; Hansen HH
Cancer Chemother Pharmacol; 1992; 31(1):46-52. PubMed ID: 1360876
[TBL] [Abstract][Full Text] [Related]
7. Diversity of DNA damage response of astrocytes and glioblastoma cell lines with various p53 status to treatment with etoposide and temozolomide.
Sato Y; Kurose A; Ogawa A; Ogasawara K; Traganos F; Darzynkiewicz Z; Sawai T
Cancer Biol Ther; 2009 Mar; 8(5):452-7. PubMed ID: 19305157
[TBL] [Abstract][Full Text] [Related]
8. The alkylphospholipid perifosine induces apoptosis and p21-mediated cell cycle arrest in medulloblastoma.
Kumar A; Fillmore HL; Kadian R; Broaddus WC; Tye GW; Van Meter TE
Mol Cancer Res; 2009 Nov; 7(11):1813-21. PubMed ID: 19887560
[TBL] [Abstract][Full Text] [Related]
9. Loss of O⁶-methylguanine-DNA methyltransferase confers collateral sensitivity to carmustine in topoisomerase II-mediated doxorubicin resistant triple negative breast cancer cells.
Raguz S; Adams C; Masrour N; Rasul S; Papoutsoglou P; Hu Y; Cazzanelli G; Zhou Y; Patel N; Coombes C; Yagüe E
Biochem Pharmacol; 2013 Jan; 85(2):186-96. PubMed ID: 23122841
[TBL] [Abstract][Full Text] [Related]
10. Moxifloxacin enhances etoposide-induced cytotoxic, apoptotic and anti-topoisomerase II effects in a human colon carcinoma cell line.
Reuveni D; Halperin D; Shalit I; Priel E; Fabian I
Int J Oncol; 2010 Aug; 37(2):463-71. PubMed ID: 20596674
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cyclin A kinase activity in E2F-1 chemogene therapy of colon cancer.
Elliott MJ; Baker JD; Dong YB; Yang HL; Gleason JF; McMasters KM
Tumour Biol; 2002; 23(6):324-36. PubMed ID: 12677090
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of phosphatidylinositol 3-kinase promotes tumor cell resistance to chemotherapeutic agents via a mechanism involving delay in cell cycle progression.
McDonald GT; Sullivan R; Paré GC; Graham CH
Exp Cell Res; 2010 Nov; 316(19):3197-206. PubMed ID: 20736003
[TBL] [Abstract][Full Text] [Related]
13. Antagonism between curcumin and the topoisomerase II inhibitor etoposide: a study of DNA damage, cell cycle regulation and death pathways.
Saleh EM; El-awady RA; Eissa NA; Abdel-Rahman WM
Cancer Biol Ther; 2012 Sep; 13(11):1058-71. PubMed ID: 22895066
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of MDM2 inhibitor MI-219 against lung cancer cells alone or in combination with MDM2 knockdown, a XIAP inhibitor or etoposide.
Zheng M; Yang J; Xu X; Sebolt JT; Wang S; Sun Y
Anticancer Res; 2010 Sep; 30(9):3321-31. PubMed ID: 20944104
[TBL] [Abstract][Full Text] [Related]
15. Polyadenylate polymerase modulations in human epithelioid cervix and breast cancer cell lines, treated with etoposide or cordycepin, follow cell cycle rather than apoptosis induction.
Thomadaki H; Tsiapalis CM; Scorilas A
Biol Chem; 2005 May; 386(5):471-80. PubMed ID: 15927891
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of genistein and BCNU on growth inhibition and cytotoxicity of glioblastoma cells.
Khoshyomn S; Nathan D; Manske GC; Osler TM; Penar PL
J Neurooncol; 2002 May; 57(3):193-200. PubMed ID: 12125982
[TBL] [Abstract][Full Text] [Related]
17. Permanent cell cycle arrest in asynchronously proliferating normal human fibroblasts treated with doxorubicin or etoposide but not camptothecin.
Robles SJ; Buehler PW; Negrusz A; Adami GR
Biochem Pharmacol; 1999 Aug; 58(4):675-85. PubMed ID: 10413306
[TBL] [Abstract][Full Text] [Related]
18. Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.
Groh T; Hrabeta J; Poljakova J; Eckschlager T; Stiborova M
Neuro Endocrinol Lett; 2012; 33 Suppl 3():16-24. PubMed ID: 23353839
[TBL] [Abstract][Full Text] [Related]
19. The role of MAPK pathways in the action of chemotherapeutic drugs.
Boldt S; Weidle UH; Kolch W
Carcinogenesis; 2002 Nov; 23(11):1831-8. PubMed ID: 12419831
[TBL] [Abstract][Full Text] [Related]
20. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
